Arrhythmogenic Delayed Afterdepolarizations Are Promoted by Severe Hypothermia But Not Therapeutic Hypothermia

Hidehira Fukaya1,2, Joseph S Piktel1,3, Xiaoping Wan1

  • 1The Heart and Vascular Research Center, MetroHealth Campus, Case Western Reserve University.

Insights

Severe hypothermia (SH) increases arrhythmia risk by enhancing calcium release, unlike therapeutic hypothermia (TH). TH suppresses calcium release, preventing triggered activity and associated arrhythmias.

Area of Science:

  • Cardiology
  • Physiology
  • Biophysics

Background:

  • Severe hypothermia (SH) is arrhythmogenic, but its effect on arrhythmias compared to therapeutic hypothermia (TH) is unclear.
  • Hypothesized that SH, not TH, increases susceptibility to calcium-mediated arrhythmia triggers.

Purpose of the Study:

  • To investigate the effects of SH and TH on calcium handling and arrhythmia triggers.
  • To determine the temperature-dependent mechanisms underlying hypothermia-induced arrhythmias.

Main Methods:

  • Optical mapping of spontaneous calcium release (SCR) and delayed afterdepolarizations (DADs) in canine wedge preparations at normothermia (36°C), TH (32°C), and SH (28°C).
  • Evaluation of isolated myocyte calcium release kinetics and sarcoplasmic reticulum (SR) calcium content.
  • Assessment of calcium spark frequency and ryanodine receptor activity.

Main Results:

  • Therapeutic hypothermia (TH) suppressed multicellular SCR slope and DAD amplitude, preventing triggered activity.
  • Severe hypothermia (SH) significantly increased SCR slope and DAD amplitude, leading to triggered activity.
  • SH markedly increased Ca spark frequency, suggesting increased ryanodine receptor open probability, while SR Ca content remained similar between TH and SH.

Conclusions:

  • Temperature-dependent alterations in calcium release explain the increased susceptibility to arrhythmia triggers in SH.
  • SH increases the risk of lethal arrhythmias due to enhanced calcium release, whereas TH does not.
  • Findings differentiate the arrhythmogenic potential of SH from the protective effects of TH on cardiac electrophysiology.
Abstract

Related Concept Videos

Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.1K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
3.8K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.1K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.4K
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
7.5K
Homeostatic Imbalances in Body Temperature01:19

Homeostatic Imbalances in Body Temperature

Hyperthermia occurs when the body's temperature becomes unusually high, often due to heat exposure, intense physical activity, or certain illnesses. This condition can create a dangerous cycle where elevated body temperature increases the metabolic rate, generating more heat and potentially leading to organ failure and brain damage. A severe form of hyperthermia, called heat stroke, can raise body temperature to life-threatening levels. Fever, on the other hand, is a controlled form of...
4.3K